Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Betta Pharmaceuticals Co., Ltd.
Age
18–70
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Locally advanced, unresectable or metastatic pancreatic cancer by histologic or cytologic confirmation without previous chemotherapy or target therapy.
ECOG Performance Status of 0 to 1.
Adequate organ function as defined by study-specified laboratory tests.
Signed informed consent form.
Willing and able to comply with study procedures.
You may not be if
Previous chemotherapy or target therapy.
Currently have or have history of certain study-specified heart, liver, kidney, lung, neurological, immune or other medical conditions.
Systemically active steroids.
Another investigational product within 28 days prior to receiving study drug.
Major surgery or significant traumatic injury (or unhealed surgical wounds) occurring within 28 days prior to receiving study drug.
Infection with HIV, hepatitis B or C at screening.
Pregnant or lactating.
Conditions, including alcohol or drug dependence, or intercurrent illness that would affect the patient's ability to comply with study visits and procedures.
